Skip to main content

Protein A Resin Market Size to Grow at a CAGR of 5.2% During the Forecast Period 2021-2026

Rapid Increase in Demand for Therapeutic Antibodies Driving the Growth of Protein a Resin Market.

Hyderabad, India - July 22, 2021 /MarketersMedia/

Protein A Resin Market size was valued at $1,037 million in 2020, and is anticipated to grow at a CAGR of 5.2% during the forecast period 2021-2026. The protein A resin industry growth rate is attributed to the increase in awareness and rising prevalence of research in monoclonal antibodies. Protein A chromatography is the most frequently used affinity chromatography method in bio-manufacturing. It is the standard technique for capturing recombinant monoclonal antibodies, which relies on the reversible and specific binding between the immobilized protein A ligand and antibodies. Protein A Resin can also be used for immunoprecipitation of proteins, protein complexes or antigens. The recombinant protein A ligand is coupled to 4% agarose. The coupling is optimized to give high binding capacity for immunoglobulins. The static binding capacity of Protein A Resin is greater than 20 mg human IgG/ml settled resin. The dynamic binding capacity will vary depending on several factors such as target antibody, flow rate etc. Apart from this, in a recent study conducted by the European Medicine Agency, in 2019, around 66 new medicines and 30 new active substances were approved in the Europe; which in turn support’s the fact that there is a high growing consciousness amongst the population that has fostered the demand for protein A resin products. However, high cost of Protein A Resin products purification are among the major factors obstructing market development during the forecast period 2021-2026.

Protein A Resin Market Segment Analysis - By Application

In 2020, on the basis of application, antibody purification segment accounted for the largest segmental revenue of the protein A resin market. The antibody purification held the largest market on account of the fact that this form of purification is rising in demand amongst various end users be it therapeutic or for research purposes. Also, there is commercial production and purification of mAb owing to the increasing demand for monoclonal antibodies hence, the antibody form of purification is to supplement the segment development. On the contrary, immunoprecipitation segment is projected to witness healthy growth throughout the forecast period 2021-2026 with a CAGR of 5.80% since the usage of immunoprecipitation has been on the upswing owing to the fact that it’s proved efficient in the identification of S-glutathionylation in target proteins. Furthermore, its technical advancements and increased practical usages is poised to fuel the sector growth in the application segment during the forecast period 2021-2026.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=508404
Report Price: $ 5900 (Single User License)

Protein A Resin Market Segment Analysis - By End User

On the basis of end user, biopharmaceutical manufacturers segment accounted for the largest segmental revenue of the Protein A Resin market in 2020. The large share can be attributed to the global rise in the number’s for R&D expenditure of pharmaceutical and biopharmaceutical companies is attributed to positively affect market growth during the forecast period 2021-2026. On the other hand, clinical research laboratories segment is projected to dominate over the forecast period 2021-2026 with a CAGR of 5.50%. The clinical research laboratories are to witness a healthy growth owing to the fact that the increasing usage of various automated dispensing cabinets to enhance productivity and efficiency has been driving the clinical research laboratories segment across the globe. Furthermore, one of the major factors contributing to its fastest growth is the increased investment in clinical research laboratories infrastructures are anticipated to stimulate market growth during the forecast period 2021-2026.

Protein A Resin Market Segment Analysis - By Geography

North America is the major region dominating the Protein A Resin market with a market share of 34.89% in the year 2020. This can be attributed to the fact that the presence of well-established infrastructure, key market players as well the constantly investing into research and development activities. Furthermore, rising prevalence of chronic diseases coupled with increasing demand of technologically advanced products favor the U.S. protein A resins market growth, which further fuels the regional market.

However, Asia-Pacific is projected to be the significant-growing market during the forecast period 2021-2026 as several countries such as India and China has a rising prevalence of various government initiatives followed by enhanced pharmaceutical companies markets which is poised to propel the market growth throughout the protein A resin market forecast period 2021-2026.

Protein A Resin Market Drivers

Rapid Increase In Demand For Therapeutic Antibodies

The Protein A Resin market is poised to receive upswing owing to the rapid increase in demand for therapeutic antibodies including neurological, autoimmune, and inflammatory disorders that has resulted in all major pharmaceutical companies focusing on the R&D of therapeutic antibodies. Hence, there is a rising use of chromatography resins in drug discovery and research industry and is to propel the market growth over the forecast period 2021-2026.

Protein A Resin Market Challenges

High Cost Of Protein A Resin Purification

One of the major factors restricting the Protein A Resin procedures in many countries around the world is owing to high cost of Protein A Resin purification that are obstructing market development during the forecast period 2021-2026. Moreover, with the high demand in the availability of protein A resin the prices are fluctuating for the final product and thereby, facing challenges.

Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=508404

Protein A Resin Market Landscape

The Protein A Resin market top 10 companies are Thermo Fisher Scientific, Repligen, Purolite Life Sciences, Expedeon Ltd, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, GE Healthcare and others.

Acquisitions/Product Launches

In December 2019, World Health Organization (WHO) prequalified its first bio-similar medicine trastuzumab, a monoclonal antibody for the treatment of early stage breast cancer.

Key Takeaways

The factors such as rise in awareness regarding various Protein A Resins owing to rising demand for mAb are amongst the major factor projected to impel growth of protein A resin market.

Additionally, factors such as rise in the demand in therapeutics for antibodies and increasing number of research and development activities are to create opportunities paving a way for the growth in the market during forecast period 2021-2026.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 970-236-3677
Website: https://www.industryarc.com

Source URL: https://marketersmedia.com/protein-a-resin-market-size-to-grow-at-a-cagr-of-52-during-the-forecast-period-2021-2026/89038007

Source: MarketersMedia

Release ID: 89038007

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.